Tag: clinical outsourcing

Documenting Auditing External Partners for Audits, Health Authority Queries and Due Diligence Documenting Auditing External Partners for Audits, Health Authority Queries and Due Diligence In the rapidly evolving landscape of clinical trials, ensuring compliance with regulatory standards is paramount for sponsors and clinical research organizations. This guide serves as a comprehensive resource for clinical operations,…

Read More “Documenting Auditing External Partners for Audits, Health Authority Queries and Due Diligence” »

Digital Tools and Automation That Transform Auditing External Partners in Clinical Development Auditing external partners in clinical development is an essential aspect of maintaining regulatory compliance and ensuring the integrity of clinical trial processes. This comprehensive guide will explore the role of digital tools and automation in enhancing the auditing process, with a focus on…

Read More “Digital Tools and Automation That Transform Auditing External Partners in Clinical Development” »

Case Studies: Auditing External Partners That Rescued High-Risk Studies and Vendors Case Studies: Auditing External Partners That Rescued High-Risk Studies and Vendors In the complex landscape of clinical trials, particularly those categorized as high-risk, the role of external partners has become increasingly significant. Properly auditing these partnerships is not only essential for assessing their contribution…

Read More “Case Studies: Auditing External Partners That Rescued High-Risk Studies and Vendors” »

Integrating Auditing External Partners With QMS, Risk Registers and Governance Committees Integrating Auditing External Partners With QMS, Risk Registers and Governance Committees In the rapidly evolving landscape of clinical trials, effective vendor oversight has emerged as a critical component of ensuring compliance with regulatory requirements and achieving study success. This article provides a comprehensive step-by-step…

Read More “Integrating Auditing External Partners With QMS, Risk Registers and Governance Committees” »

Future-Proofing Auditing External Partners for AI, Real-World Data and Platform Trials Future-Proofing Auditing External Partners for AI, Real-World Data and Platform Trials In an era marked by rapid technological advancements and the growing significance of real-world data, the landscape of clinical trials demands a proactive approach to vendor oversight and external auditing. Auditing external partners…

Read More “Future-Proofing Auditing External Partners for AI, Real-World Data and Platform Trials” »

Aligning Auditing External Partners With ICH E6(R3), GCP and Quality-by-Design Principles The successful execution of clinical trials heavily relies on the quality and reliability of external partners, including contract research organizations (CROs), laboratories, and other third-party vendors. As clinical research professionals in the US, UK, and EU navigate the complexities of compliance and operational efficiency,…

Read More “Aligning Auditing External Partners With ICH E6(R3), GCP and Quality-by-Design Principles” »

Auditing External Partners Checklists for Clinical Operations and Vendor Governance Teams Auditing External Partners Checklists for Clinical Operations and Vendor Governance Teams The success of clinical trials hinges not just on scientific rigor and regulatory compliance, but also on effective partnerships with external vendors. This article provides a step-by-step tutorial to guide clinical operations and…

Read More “Auditing External Partners Checklists for Clinical Operations and Vendor Governance Teams” »

Common Pitfalls in Auditing External Partners—and How to Avoid Regulatory Findings Common Pitfalls in Auditing External Partners—and How to Avoid Regulatory Findings Auditing external partners in clinical trials is a critical component for ensuring compliance with regulatory standards and maintaining the integrity of clinical research. Given the complexity of clinical trials in my area, understanding…

Read More “Common Pitfalls in Auditing External Partners—and How to Avoid Regulatory Findings” »